JFS Wealth Advisors’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$226 Buy
+11
New +$252 ﹤0.01% 2127
2024
Q2
Sell
-33
Closed -$867 1994
2024
Q1
$867 Sell
33
-4
-11% -$114 ﹤0.01% 1687
2023
Q4
$1.17K Sell
37
-29
-44% -$787 ﹤0.01% 1616
2023
Q3
$1.85K Sell
66
-18
-21% -$618 ﹤0.01% 1388
2023
Q2
$3.1K Hold
84
﹤0.01% 1212
2023
Q1
$2.52K Sell
84
-16
-16% -$527 ﹤0.01% 1275
2022
Q4
$3.06K Sell
100
-3
-3% -$90 ﹤0.01% 1205
2022
Q3
$3K Sell
103
-60
-37% -$1.98K ﹤0.01% 1153
2022
Q2
$5K Buy
163
+89
+120% +$3.27K ﹤0.01% 975
2022
Q1
$2K Buy
74
+40
+118% +$1.25K ﹤0.01% 1385
2021
Q4
$1K Buy
+34
New +$1.06K ﹤0.01% 1287
2019
Q2
Sell
-80
Closed -$3K 462
2019
Q1
$3K Buy
+80
New +$2.91K ﹤0.01% 417
2018
Q2
Sell
-12
Closed -$1K 472
2018
Q1
$1K Sell
12
-40
-77% -$2K ﹤0.01% 495
2017
Q4
$3K Buy
52
+40
+333% +$2.1K ﹤0.01% 457
2017
Q3
$1K Buy
+12
New +$566 ﹤0.01% 426

Other funds holding CC

JFS Wealth Advisors's CC Position: Q2 2026 in Review

JFS Wealth Advisors opened a new position in Chemours (CC) in Q2 2026: 11 shares worth $226. The stake represents ﹤0.01% of the portfolio and ranks #2127 among its holdings. This is a return to the name: JFS Wealth Advisors previously reported a position in CC as recently as Q1 2024.

JFS Wealth Advisors first reported a position in CC in Q3 2017 and has held it in 15 quarters since. The position peaked at $5K in Q2 2022. 472 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • JFS Wealth Advisors held 11 shares of Chemours worth $226 as of Q2 2026.
  • Chemours was a new JFS Wealth Advisors position in Q2 2026.
  • Chemours made up ﹤0.01% of JFS Wealth Advisors's portfolio in Q2 2026, its #2127 holding.
  • JFS Wealth Advisors first reported a position in Chemours in Q3 2017 and has held it in 15 quarters since.
  • JFS Wealth Advisors's Chemours position peaked at $5K in Q2 2022.
  • 472 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on JFS Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.